Veridian Biotechnology mainly focuses on developing solutions to treating bleeding disorders or cancer. They possess the technology of handling large protein drugs and employing mammalian cell factories to produce similar biomolecules for medical use. Their first product line mainly treats bleeding disorders which lack the necessary blood clotting factors, they are able to replicate biosimilars of the factors to treat the disorders.
| Company Name | Veridian Biotechnology Limited |
| Brand Name | Veridian Biotechnology |
| Industries | BioTech |
| Year of Establishment | / |
| Founder(s) | Wong Kwok Lik Ye Bin |
| No. of Employees | / |
| Regional Coverage | / |
| Clients | / |
| Stage | / |
| Investor(s) | / |
| Raising Fund | / |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Fundraising target | / |
| Fundraising History | / |
| Media Explosure | 0-5 |
| Company Email | [email protected] |
[dcb id=5586]